CDC Ranks 19 Drug-Resistant Pathogens by Threat
The 2026 Antimicrobial Resistance Threats Report sorts bacterial and fungal pathogens into four threat levels, and lowers C. difficile's rating.
Updated on Nov. 11, 2026 in Diseases — General

Live Poll
Do you think drug-resistant infections are a growing threat to your health?
The U.S. Centers for Disease Control and Prevention published its 2026 Antimicrobial Resistance Threats Report on October 26, 2026, categorizing 19 bacterial and fungal pathogens by threat level to health in the United States. The report lowered the threat level of Clostridioides difficile from Urgent to Serious after measured declines in cases.
Why it matters
The ratings guide where prevention and treatment resources are directed, based on clinical and economic impact, current and projected infections, transmissibility, and the availability of preventive measures and effective treatments. Candida auris, carbapenem-resistant Acinetobacter, carbapenem-resistant Enterobacterales, and drug-resistant Neisseria gonorrhoeae remain classified as Urgent threats.
The report is a federal threat assessment that rates 19 pathogens across four levels, with Clostridioides difficile moved from Urgent to Serious following measured case declines. The impact of drug-resistant dermatophytes remains undetermined and is being monitored as a potential threat.
The players
Centers for Disease Control and Prevention (CDC)
The U.S. federal public health agency that publishes national antimicrobial resistance surveillance and threat assessments.
The details
The report added drug-resistant Neisseria meningitidis as a Serious threat and placed drug-resistant dermatophytes, drug-resistant Haemophilus influenzae, and nontuberculous mycobacteria on the Watch List. CDC also expanded C. difficile data collection to include hospital and community cases, and broadened surveillance of resistant Enterobacterales and drug-resistant group A Streptococcus.
Timeline
October 26, 2026: CDC published the Antimicrobial Resistance Threats Report.
November 11, 2026: Contagion Live published an article on the report.
Big Picture
The 2026 report extends CDC's established Urgent, Serious, Concerning, and Watch List framework, reclassifying C. difficile downward while adding drug-resistant Neisseria meningitidis to the Serious tier. It shows how the agency's tiered threat system is being updated as surveillance data change.
Clinicians and patients are affected when resistant infections become harder to treat, so the ratings influence how hospitals screen and manage infections. The lower C. difficile rating reflects fewer cases, while Urgent-tier pathogens continue to require careful infection control.
The takeaway
Hospital and community infection-control practices remain essential for the pathogens still rated Urgent. Staying current with CDC's updated threat levels can help clinicians and patients understand where resistance risks are shifting.
Further reading
Explore more on Diseases — General for broader context on how these pathogens affect the population.
More information
Read the full CDC Antimicrobial Resistance Threats Reports on the agency's official website.
Live Poll
Do you think drug-resistant infections are a growing threat to your health?










